Answers are grounded in this paper and cite their sources.
Case report reveals successful resolution of steroid-refractory cytopenias with low-dose tacrolimus in lupus-associated hemophagocytic syndrome, suggesting an effective adjunctive therapy.
Hemophagocytic syndrome (HPS) is an unusual disorder associated with systemic lupus erythematosus (SLE). A 64-year-old woman was admitted because of fever and urticarial vasculitis. Laboratory data revealed pancytopenia and immunological abnormalities, suggesting elevated disease activity. Prednisolone monotherapy failed to improve the pancytopenia despite the amelioration of other clinical findings. Because her condition was suggestive of HPS, tacrolimus at 2–3 mg/day was added to the prednisolone regimen. Eventually, the pancytopenia improved and prednisolone could be effectively tapered. Tacrolimus could be an additional or alternative modality for treating refractory HPS.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: